I-Mab to Participate at the Piper Sandler Healthcare Conference

Newest

WALLX First Halving to Lanch on August 20, Marking the Full Start of Phase Two — From Ten Million Consensus to a Global Mental Health Value Revolution
smoke fills aircraft cabin after phone charger catches fire onboard
everything you need to know about new europe travel rules coming within weeks
stunning pictures show how sturgeon moon lit up skies around the world

Links

I-Mab to Participate at the Piper Sandler Healthcare Conference

2024-11-22 I-Mab Biopharma HaiPress

The 36th Annual Healthcare Conference will be held in New York,December 3-5,2024

ROCKVILLE,Md.,Nov. 21,2024 -- I-Mab (NASDAQ: IMAB,the "Company"),a U.S.-based global biotech company,exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer,today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4,2024.

Piper Sandler 36th Annual Healthcare Conference Presentation Details

Presentation Time

Wednesday,December 4 at4:30 p.m. ET

Presenters

Sean Fu,PhD,MBA,Chief Executive Officer

Phillip Dennis,MD,Chief Medical Officer

Webcast link

Here

Meetings

One-on-one and small group meetings:December 3 – 4,2024

Management

Participants

Sean Fu,Chief Executive Officer

Joseph Skelton,Chief Financial Officer

Phillip Dennis,Chief Medical Officer

Tyler Ehler,Senior Director,Investor Relations

The webcast will also be available under "Event Calendar" onI-Mab'sIR website

athttps://ir.i-mabbiopharma.com/

For more information,please contact your Piper Sandler representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based,global biotech company,exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville,Maryland,and Short Hills,New Jersey. For more information,please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information,please contact:

Tyler Ehler

Senior Director,Investor Relations

IR@imabbio.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.